Clinical Trial Update: To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial evaluating therapeutic equivalence and safety of tretinoin cream 0.05% versus the reference listed drug in acne vulgaris. The study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Reference Listed Drug (RLD) for Tretinoin Cream 0.05% (tretinoin)
• Tretinoin Cream 0.05% (tretinoin)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Acne Vulgaris | EARLY_Phase 1 | Status: COMPLETED